Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB/c mice

Life Sciences

Volumn 76, Issue 19, 2005, Pages 2269-2273

  Cheng, Chih Ya ^a   Hong, Chen Jee ^b,c   Tsai, Shih Jen ^b,c  

^a CHING KUO INSTITUTE OF MANAGEMENT AND HEALTH   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Body weight; Cholesterol; Clozapine; Glucose; Mouse; Triglyceride

Indexed keywords

CHOLESTEROL; CLOZAPINE; GLUCOSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHRONIC TOXICITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 14044280073     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.12.004     Document Type: Article

References (11)

1. T. Baptista, A. Mata, L. Teneud, M. de Quijada, H.W. Han, and L. Hernandez Effects of long-term administration of clozapine on body weight and food intake in rats Pharmacology Biochemistry and Behavior 45 1 1993 51 54
2. T. Baptista, M. Parada, and L. Hernandez Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacology Biochemistry and Behavior 27 3 1987 399 405
3. D.C. Henderson, E. Cagliero, C. Gray, R.A. Nasrallah, D.L. Hayden, D.A. Schoenfeld, and D.C. Goff Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study American Journal of Psychiatry 157 6 2000 975 981
4. D.C. Henderson Clozapine: diabetes mellitus, weight gain, and lipid abnormalities Journal of Clinical Psychiatry 62 Suppl. 23 2001 39 44
5. M.C. Jong, V.E. Dahlmans, P.J. van Gorp, K.W. van Dijk, M.L. Breuer, M.H. Hofker, and L.M. Havekes In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway Journal of Clinical Investigation 98 10 1996 2259 2267
6. J.P. Lindenmayer, P. Czobor, J. Volavka, L. Citrome, B. Sheitman, J.P. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics American Journal of Psychiatry 160 2 2003 290 296
7. C. Rolsten, J. Claghorn, and T. Samorajski Long-term treatment with clozapine on aging mice Life Sciences 25 10 1979 865 872
8. A. Safferman, J.A. Lieberman, J.M. Kane, S. Szymanski, and B. Kinon Update on the clinical efficacy and side effects of clozapine Schizophrenia Bulletin 17 2 1991 247 261
9. N.S. Shachter, T. Ebara, R. Ramakrishnan, G. Steiner, J.L. Breslow, H.N. Ginsberg, and J.D. Smith Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl Journal of Clinical Investigation 98 3 1996 846 855
10. R.H. Waterston, K. Lindblad-Toh, E. Birney, J. Rogers, J.F. Abril, and P. Agarwal Initial sequencing and comparative analysis of the mouse genome Nature 420 2002 520 562
11. D.A. Wirshing, J.A. Boyd, L.R. Meng, J.S. Ballon, S.R. Marder, and W.C. Wirshing The effects of novel antipsychotics on glucose and lipid levels Journal of Clinical Psychiatry 63 10 2002 856 865